natgillin/translations-raw huggingface dataset:
In controlled clinical studies, use of epoetin alfa and other ESAs have been associated with decreased locoregional tumour control or decreased overall survival:
V nadzorovanih kliničnih študijah je bila uporaba epoetina alfa in drugih ESA povezana z zmanjšanim lokoregionalnim nadzorom tumorjev ali zmanjšanim skupnim preživetjem:
If you visit a hospital, clinic or family doctor, tell them you are having Abseamed treatment.
Če obiščete bolnišnico, kliniko ali izbranega zdravnika, povejte, da se zdravite z zdravilom
The dose of Abseamed you receive is based on your body weight in kilograms.
Odmerek zdravila Abseamed, ki ga boste prejeli, je odvisen od vaše telesne mase v kilogramih.
Abseamed is given alone and not mixed with other liquids for injection.
Zdravilo Abseamed se daje samo in se ne meša z drugimi tekočinami za injiciranje.
Inject the Abseamed solution as you have been shown by your doctor.
Injicirajte raztopino zdravila Abseamed, kot vam je pokazal zdravnik.
When this access (via a vein or tube) is not readily available, your doctor may decide that Abseamed should be injected under the skin (subcutaneously).
Kadar takšen dostop (v veno ali cevko) ni takoj na razpolago, se vaš zdravnik lahko odloči, da je treba zdravilo Abseamed injicirati pod kožo (subkutano).
• Your doctor may initiate treatment with Abseamed if your haemoglobin is 10 g/dL or less.
• Vaš zdravnik lahko uvede zdravljenje z zdravilom Abseamed, ko je vaš hemoglobin 10 g/dl ali manj.
If you are a cancer patient, be aware that use of Abseamed may be associated with shorter survival and a higher death rate in head and neck, and metastatic breast cancer patients who are receiving chemotherapy.
Če ste bolnik z rakom, morate vedeti, da je uporaba zdravila Abseamed lahko povezana s krajšim preživetjem in večjimi stopnjami smrtnosti pri bolnikih z rakom v glavi in vratu ter metastatskim rakom dojke, ki prejemajo zdravljenje s kemoterapijo.
< 1/100); rare (≥ 1/10,000 to < 1/1,000); very rare (< 1/10,000), not known (cannot be estimated from the available data).
Ocena pogostnosti: zelo pogosti (≥ 1/10); pogosti (≥ 1/100 do < 1/10); občasni (≥ 1/1.000 do < 1/100); redki (≥ 1/10.000 do < 1/1.000); zelo redki (< 1/10.000), neznana pogostnost (ni mogoče oceniti iz razpoložljivih podatkov).
• If you are having dialysis treatment when you begin treatment with Abseamed, your dialysis regime may need to be adjusted.
• Če se zdravite z dializo, ko se začenjate zdraviti z zdravilom Abseamed, bo morda treba prilagoditi vaš režim dialize.
• Always use Abseamed exactly as instructed by your doctor or nurse.
• Zdravilo Abseamed vedno uporabljajte natančno po navodilih svojega zdravnika ali medicinske sestre.
During the maintenance phase, Abseamed can be administered either 3 times per week, and in the case of subcutaneous administration, once weekly or once every 2 weeks.
Med vzdrževalno fazo se lahko zdravilo Abseamed daje bodisi 3-krat na teden ali v primeru subkutanega dajanja enkrat na teden ali enkrat na dva tedna.
You may still be able to use Abseamed, but discuss it with your doctor first:
Morda boste lahko še vedno uporabljali zdravilo Abseamed, vendar se najprej posvetujte s svojim zdravnikom:
If you forget to use Abseamed
Če ste pozabili uporabiti zdravilo Abseamed
Do not administer Abseamed by intravenous infusion or in conjunction with other medicinal product solutions (please refer to section 6.6 for further information).
Zdravila Abseamed ne dajajte v obliki intravenske infuzije ali v povezavi z drugimi raztopinami zdravil (glejte poglavje 6.6 za dodatne informacije).
In those situations in which the physician determines that a patient or caregiver can safely and effectively administer Abseamed subcutaneously themselves, instruction as to the proper dosage and administration should be provided.
Če zdravnik oceni, da lahko bolnik ali negovalec zdravilo Abseamed varno in učinkovito subkutano injicira sam, mu je treba dati navodila za pravilno odmerjanje in dajanje.
• You will usually continue Abseamed treatment for one month after the end of chemotherapy.
• Običajno boste zdravilo Abseamed dobivali še en mesec po končanem zdravljenju s kemoterapijo.
• If you do not respond adequately to Abseamed, your doctor will check your dose and will inform you if you need to change doses of Abseamed.
• Če se na zdravljenje z zdravilom Abseamed ne odzivate ustrezno, bo zdravnik preveril vaš odmerek in vas obvestil, če morate spremeniti odmerke zdravila Abseamed.
If Abseamed is injected under the skin (subcutaneously), the amount injected is not normally more than one millilitre (1 mL) in a single injection.
Če se zdravilo Abseamed injicira pod kožo (subkutano), se z eno injekcijo navadno ne injicira količina, večja kot en mililiter zdravila (1 ml).
For patients on peritoneal dialysis Abseamed may be given twice a week.
Bolniki na peritonealni dializi lahko dobivajo zdravilo Abseamed dvakrat na teden.
• Abseamed is given by injection into a vein immediately after you have donated blood for 3 weeks before your surgery.
• Zdravilo Abseamed se injicira v veno takoj po tem, ko darujete kri, 3 tedne pred kirurškim posegom.
• difficulty swallowing or breathing,
• težave s požiranjem ali dihanjem,
• if you have been diagnosed with Pure Red Cell Aplasia (the bone marrow cannot produce enough red blood cells) after previous treatment with any product that stimulates red blood cell production (including Abseamed).
• če so vam postavili diagnozo aplazija rdečih krvnih celic (kostni mozeg ne more tvoriti dovolj rdečih krvnih celic) po predhodnem zdravljenju s katerim koli zdravilom, ki spodbuja nastajanje rdečih krvnih celic (vključno z zdravilom Abseamed).
Because Abseamed stimulates the production of red blood cells, doctors can take more blood from these people.
Ker zdravilo Abseamed spodbuja nastajanje rdečih krvnih celic, lahko zdravnik od teh ljudi vzame več krvi.
Your doctor has carried out blood tests and decided you need Abseamed.
Vaš zdravnik je opravil krvne preiskave in odločil, da potrebujete zdravilo Abseamed.
In the 20-week study (n = 225), no significant difference was observed in the primary efficacy endpoint, i.e. the proportion of patients who required a RBC transfusion after Day 28 (62% of epoetin alfa patients versus 69% of standard therapy patients).
V 20-tedenski študiji (n = 225) niso opazili značilnih razlik v primarnem opazovanem dogodku učinkovitosti, tj. v deležu bolnikov, pri katerih je bila potrebna transfuzija RKC po 28. dnevu (62 % bolnikov z epoetinom alfa v primerjavi z 69 % bolnikov s standardnim zdravljenjem).
Your doctor will help you to decide if Abseamed is suitable for you.
Vaš zdravnik vam bo pomagal pri odločitvi, ali je zdravilo Abseamed za vas primerno.
While on Abseamed, some people need medicines to reduce the risk of blood clots.
Med uporabo zdravila Abseamed morajo nekatere osebe jemati zdravila za zmanjšanje tveganja za nastanek krvnih strdkov.
Later, your doctor may suggest that you or your caregiver learn how to inject Abseamed under the skin
Kasneje lahko zdravnik predlaga, da se vi ali vaš skrbnik naučite, kako si injicirati zdravilo Abseamed pod kožo (subkutano).
• The usual starting dose of Abseamed for adults and children is 50 International Units (IU) per kilogram (/kg) of body weight given three times a week.
• Običajni začetni odmerek zdravila Abseamed za odrasle in otroke je 50 mednarodnih enot (i.e.) na kilogram (/kg) telesne mase, trikrat na teden.
- Patients who develop pure red cell aplasia (PRCA) following treatment with any erythropoietin should not receive Abseamed or any other erythropoietin (see section 4.4).
- Bolniki, pri katerih se po zdravljenju s katerim koli eritropoetinom razvije aplazija rdečih krvnih celic (PRCA - pure red cell aplasia), ne smejo dobivati zdravila Abseamed ali katerega koli drugega eritropoetina (glejte poglavje 4.4).
• Abseamed is given by injection under the skin each week for three weeks before surgery and on the day of surgery.
• Zdravilo Abseamed se injicira pod kožo vsak teden tri tedne pred kirurškim posegom in na dan kirurškega posega.
Iron supplements and other blood stimulants may increase the effectiveness of Abseamed.
Dodatki železa in druga sredstva za spodbujanje tvorbe krvi lahko povečajo učinkovitost zdravila
Abseamed and other products that stimulate red cell production may increase the risk of developing blood clots in all patients.
Zdravilo Abseamed in druga zdravila, ki spodbujajo nastajanje rdečih krvnih celic, lahko povečajo tveganje za nastanek krvnih strdkov pri vseh bolnikih.
Abseamed may be given by injection:
Zdravilo Abseamed se lahko daje z injiciranjem:
Abseamed is indicated in adults in a predonation programme to increase the yield of autologous blood.
Zdravilo Abseamed je indicirano pri odraslih v preddonorskem programu za povečanje količine pridobljene avtologne krvi.
• If you are on a more extended dosing interval (greater than once weekly) of Abseamed, you may not maintain adequate haemoglobin levels and you may require an increase in Abseamed dose or frequency of administration.
• Če uporabljate daljši interval odmerjanja zdravila Abseamed (daljši kot enkrat tedensko), morda ne bo mogoče vzdrževati ustrezne ravni hemoglobina in bo treba odmerek ali pogostnost odmerjanja zdravila Abseamed povečati.
Abseamed can reduce the need for a blood transfusion.
Zdravilo Abseamed lahko zmanjša potrebo po transfuziji krvi.
Other medicines and Abseamed
Druga zdravila in zdravilo Abseamed
• Abseamed is given by injection under the skin.
• Zdravilo Abseamed se daje v obliki injekcije pod kožo.
Abseamed is a biosimilar medicinal product.
Zdravilo Abseamed je podobno biološko zdravilo.
• Your doctor will order blood tests, and may adjust the dose, depending on how your anaemia responds to Abseamed treatment.
• Vaš zdravnik bo naročil krvne preiskave in po potrebi prilagodil odmerek, odvisno od odziva vaše anemije na zdravljenje z zdravilom Abseamed.
This section contains information on how to give yourself an injection of Abseamed.
To poglavje vsebuje navodila za to, kako morate sami sebi dajati injekcije zdravila Abseamed.
• Only use Abseamed if it has been stored correctly - see section 5, How to store Abseamed.
• Uporabljajte le pravilno shranjeno zdravilo Abseamed - glejte poglavje 5, Shranjevanje zdravila Abseamed.
Tell your doctor or nurse immediately if you are aware of any of these effects, or if you notice any other effects while you are receiving treatment with Abseamed.
Zdravniku ali medicinski sestri takoj povejte, če ugotovite katerega koli od teh neželenih učinkov ali če med zdravljenjem z zdravilom Abseamed opazite druge neželene učinke.
Caution should be exercised with escalation of Abseamed doses in patients with chronic renal failure since high cumulative epoetin doses may be associated with an increased risk of mortality, serious cardiovascular and cerebrovascular events.
Previdnost je potrebna pri stopnjevanju odmerkov zdravila Abseamed pri bolnikih s kronično ledvično odpovedjo, saj so morda višji kumulativni odmerki epoetina povezani s povečanim tveganjem za umrljivost, resne kardiovaskularne in cerebrovaskularne dogodke.
If signs and symptoms suggestive of these reactions appear, Abseamed should be withdrawn immediately and an alternative treatment considered.
Če se pojavijo znaki in simptomi, ki kažejo na te reakcije, je treba zdravljenje z zdravilom Abseamed takoj prekiniti in razmisliti o drugi vrsti zdravljenja.
Where intravenous access is not readily available (patients not yet undergoing dialysis and peritoneal dialysis patients) Abseamed may be administered as a subcutaneous injection.
Kjer intravenski dostop ni takoj na razpolago (bolniki, ki se še ne zdravijo z dializo, in bolniki na peritonealni dializi), se zdravilo Abseamed lahko daje v obliki subkutane injekcije.
Epoetin alfa 600 IU/kg (administered intravenously or subcutaneously once weekly) has been evaluated in a randomised, double-blind, placebo-controlled, 16-week study and in a randomised, controlled, open-label, 20-week study in anaemic paediatric patients receiving myelosuppressive chemotherapy for the treatment of various childhood non-myeloid malignancies.
Epoetin alfa 600 i.e./kg (dan intravensko ali subkutano enkrat na teden) so ovrednotili v randomizirani, dvojno slepi, s placebom nadzorovani, 16-tedenski študiji in v randomizirani, nadzorovani, odprti, 20-tedenski študiji pri anemičnih pediatričnih bolnikih, ki so prejemali mielosupresivno kemoterapijo za zdravljenje različnih otroških nemieloidnih malignih obolenj.
Mildly anaemic patients (haematocrit of 33 to 39%) requiring predeposit of ≥ 4 units of blood should be treated with Abseamed 600 IU/kg intravenously, 2 times per week for 3 weeks prior to surgery.
Blago anemične bolnike (hematokrit 33 do 39 %), ki potrebujejo ≥ 4 enote deponirane krvi, je treba zdraviti z zdravilom Abseamed 600 i.e./kg, intravensko, 2-krat na teden, 3 tedne pred kirurškim posegom.
Abseamed is one of a group of products that stimulate the production of red blood cells like the human protein erythropoietin does.
Zdravilo Abseamed je eno od zdravil iz skupine, ki spodbuja nastajanje rdečih krvnih celic na enak način kot humana beljakovina eritropoetin.
Abseamed can reduce the need for a blood transfusion in these patients.
Zdravilo Abseamed lahko pri teh bolnikih zmanjša potrebo po transfuziji krvi.
If you are taking a medicine called cyclosporin (used e.g. after kidney transplants), your doctor may order blood tests to check the level of cyclosporin while you are taking Abseamed.
Če med zdravljenjem z zdravilom Abseamed jemljete zdravilo, imenovano ciklosporin (uporablja se npr. po presaditvi ledvic), lahko zdravnik naroči preiskave krvi, da preveri raven ciklosporina,
You may still be able to use Abseamed, but discuss it with your doctor first.
Morda boste kljub temu lahko uporabljali zdravilo Abseamed, vendar se najprej posvetujte s svojm zdravnikom.
Patients should be monitored closely to ensure that the lowest approved effective dose of Abseamed is used to provide adequate control of anaemia and of the symptoms of anaemia whilst maintaining a haemoglobin concentration below or at 12 g/dL (7.5 mmol/L).
Bolnike je treba skrbno spremljati, da se zagotovi uporaba najmanjšega odobrenega učinkovitega odmerka zdravila Abseamed za doseganje ustreznega nadzora anemije in simptomov anemije ob hkratnem ohranjanju koncentracije hemoglobina pod ali pri 12 g/dl (7,5 mmol/l).
In patients with a poor haemoglobin response to Abseamed, alternative explanations for the poor response should be considered (see section 4.4 and 5.1).
Pri bolnikih s slabim odzivom hemoglobina na zdravilo Abseamed je treba iskati druge razlage za slab odziv (glejte poglavji 4.4 in 5.1).
Treatment with Abseamed has to be initiated under the supervision of physicians experienced in the management of patients with the above indications.
4.2 Odmerjanje in način uporabe Zdravljenje z zdravilom Abseamed je treba začeti pod nadzorom zdravnika, ki ima izkušnje z obravnavo bolnikov z zgoraj navedenimi indikacijami.
Abseamed is used in moderately anaemic adults who donate some of their blood before surgery, so that it can be given back to them during or after the operation.
Zdravilo Abseamed se uporablja za zdravljenje zmerno anemičnih odraslih, ki pred kirurškim posegom darujejo nekaj svoje krvi, da jo lahko med kirurškim posegom ali po njem dobijo nazaj.
Treatment should only be given to patients with moderate anaemia (haemoglobin [Hb] concentration range between 10 to 13 g/dL [6.2 to 8.1 mmol/L], no iron deficiency), if blood saving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males).
Zdravilo Abseamed smemo uporabiti samo pri bolnikih z zmerno anemijo (razpon koncentracije hemoglobina [Hb] od 10 do 13 g/dl [6,2 do 8,1 mmol/l] brez pomanjkanja železa), če postopki za ohranjanje krvi niso na voljo ali ne zadostujejo, kadar je za večji elektivni kirurški poseg potrebna velika količina krvi (4 ali več enot krvi za ženske ali 5 ali več enot za moške).
If you are a patient with chronic renal failure, and particularly if you do not respond properly to Abseamed, your doctor will check your dose of Abseamed because repeatedly increasing your dose of Abseamed if you are not responding to treatment may increase the risk of having a problem of the heart or the blood vessels and could increase risk of myocardial infarction, stroke and death.
Če ste bolnik s kronično ledvično odpovedjo, še zlasti, če se na zdravilo Abseamed ne odzivate ustrezno, bo zdravnik preveril vaš odmerek zdravila Abseamed, saj lahko stalno zviševanje vašega odmerka zdravila Abseamed, če se na zdravljenje ne odzivate, poveča tveganje za težave s srcem ali ožiljem in tudi tveganje za srčni infarkt, možgansko kap in smrt.
Your Abseamed dose and frequency of administration may be further adjusted to maintain your response to treatment.
Po potrebi vam lahko odmerek zdravila Abseamed in pogostnost uporabe nadalje prilagaja, da se ohrani vaš odziv na zdravljenje.
Abseamed is indicated in adults receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre-existing anaemia at the start of chemotherapy) for the treatment of anaemia and reduction of transfusion requirements.
Zdravilo Abseamed je indicirano za zdravljenje odraslih, pri katerih s kemoterapijo zdravimo solidne tumorje, maligni limfom ali multipli mielom, in pri tveganju za transfuzijo, ki ga ocenimo glede na bolnikovo splošno zdravstveno stanje (npr. kardiovaskularni status, prisotnost anemije že na začetku zdravljenja s kemoterapijo) za zdravljenje anemije in zmanjšanje potrebe po transfuziji.
If you can't take medicines that prevent blood clotting, you must not have Abseamed.
Če ne smete jemati zdravil za preprečevanje nastanka krvnih strdkov,
Abseamed is used to treat symptomatic anaemia caused by kidney disease:
Zdravilo Abseamed se uporablja za zdravljenje simptomatske anemije, ki jo povzroči bolezen ledvic:
If the patient has developed a severe cutaneous skin reaction such as SJS or TEN due to the use of Abseamed, treatment with Abseamed must not be restarted in this patient at any time.
Če je pri bolniku zaradi uporabe zdravila Abseamed prišlo do hude kožne reakcije, kot sta SJS ali TEN, zdravljenja z zdravilom Abseamed ni dovoljeno ponovno začeti.
Abseamed is presented as a clear, colourless solution for injection in a pre-filled syringe.
Zdravilo Abseamed je bistra, brezbarvna raztopina za injiciranje v napolnjeni injekcijski brizgi.
If you develop a serious rash or another of these skin symptoms, stop taking Abseamed and contact your doctor or seek medical attention immediately.
Če se je pri vas pojavil hud izpuščaj ali kateri od teh kožnih simptomov, prenehajte z jemanjem zdravila Abseamed in se takoj posvetujte z zdravnikom ali poiščite zdravniško pomoč.
The recommended dose is Abseamed 600 IU/kg, administered subcutaneously weekly for three weeks (days -21, -14 and -7) prior to surgery and on the day of surgery (day 0).
Priporočeni odmerek zdravila Abseamed je 600 i.e./kg, ki se daje subkutano tedensko v obdobju treh tednov (na 21., 14. in 7. dan) pred kirurškim posegom in na dan kirurškega posega (dan 0).
Always keeping your skin pinched, depress the plunger slowly and evenly until the entire dose has been given and the plunger cannot be depressed any further.
Med tem, ko kožo še naprej držite med palcem in kazalcem, bat počasi in enakomerno potiskajte, dokler ni vbrizgan celoten odmerek, bata pa ni mogoče potisniti še naprej.
Abseamed is indicated for non-iron deficient adults prior to major elective orthopaedic surgery, having a high perceived risk for transfusion complications to reduce exposure to allogeneic blood transfusions.
Zdravilo Abseamed je indicirano pred večjimi elektivnimi ortopedskimi kirurškimi posegi pri odraslih brez pomanjkanja železa, pri katerih obstaja veliko tveganje za zaplete pri transfuziji, za zmanjšanje izpostavljenosti alogenim transfuzijam krvi.
Your doctor will decide how Abseamed will be injected.
Vaš zdravnik se bo odločil, kako bo injicirano zdravilo Abseamed.
Abseamed is used to treat anaemia in adults with a bone marrow disorder that causes a severe disruption in the creation of blood cells (myelodysplastic syndromes).
Zdravilo Abseamed se uporablja za zdravljenje anemije pri odraslih z boleznijo kostnega mozga, ki povzroča hude motnje pri tvorjenju krvnih celic (mielodisplastičnimi sindromi).
Abseamed is used in moderately anaemic adults about to have major orthopaedic surgery (for example hip or knee replacement operations), to reduce the potential need for blood transfusions.
Zdravilo Abseamed se uporablja pri zmerno anemičnih odraslih, naročenih na večji ortopedski kirurški poseg (na primer menjava kolka ali kolena), da se zmanjša morebitna potreba po transfuziji krvi.
The use of Abseamed in patients scheduled for major elective orthopaedic surgery and not participating in an autologous blood predonation programme is contraindicated in patients with severe coronary, peripheral arterial, carotid or cerebral vascular disease, including patients with recent myocardial infarction or cerebral vascular accident.
Pri bolnikih, naročenih na večji elektivni ortopedski kirurški poseg in ki niso vključeni v program avtolognega zbiranja krvi, je uporaba zdravila Abseamed kontraindicirana, če imajo hudo koronarno, periferno arterijsko, karotidno ali cerebrovaskularno bolezen ali so nedavno preboleli miokardni infarkt ali cerebrovaskularni dogodek.
If you are given a product in this group other than Abseamed during your treatment, speak to your doctor or pharmacist before using it.
Če med zdravljenjem dobite drugo zdravilo iz te skupine, kot zdravilo Abseamed, se pred uporabo posvetujte s svojim zdravnikom ali farmacevtom.
Abseamed is not approved in the management of anaemia associated with hepatitis C.
Zdravilo Abseamed ni odobreno za obravnavanje anemije, povezane s hepatitisom C.
All special warnings and special precautions associated with autologous predonation programmes, especially routine volume replacement, should be respected.
Bolniki, naročeni na kirurški poseg, ki sodelujejo v avtolognih preddonorskih programih Upoštevati je treba vsa posebna opozorila in posebne previdnostne ukrepe, povezane z avtolognimi preddonorskimi programi, zlasti rutinsko nadomeščanje tekočine.
Alternatively, Abseamed can be administered at an initial dose of 450 IU/kg subcutaneously once weekly.
Alternativno se lahko zdravilo Abseamed daje enkrat na teden, z začetnim odmerkom 450 i.e./kg, subkutano.
Abseamed is prescribed to stimulate your bone marrow to produce more red blood cells.
Zdravilo Abseamed se predpisuje za spodbujanje kostnega mozga k tvorbi rdečih krvnih celic.
• Before use, leave the Abseamed syringe to stand until it reaches room temperature.
• Pred uporabo počakajte, da zdravilo Abseamed doseže sobno temperaturo.
Instructions on how to inject yourself with Abseamed can be found at the end of this leaflet.
Navodila za to, kako si sami injicirate zdravilo Abseamed, lahko najdete na koncu tega navodila za uporabo zdravila.
Abseamed is used to treat anaemia in adults receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma (bone marrow cancer) who may have a need for a blood transfusion.
Zdravilo Abseamed se uporablja za zdravljenje anemije pri odraslih, če prejemate kemoterapijo za solidne tumorje, maligni limfom ali multipli mielom (rak kostnega mozga), ki morda potrebujejo transfuzijo krvi.
In chronic renal failure patients the rate of increase in haemoglobin should be approximately 1 g/dL (0.62 mmol/L) per month and should not exceed 2 g/dL (1.25 mmol/L) per month to minimise risks of an increase in hypertension.
Pri bolnikih s kroničnim ledvičnim odpovedovanjem mora biti stopnja zvišanja hemoglobina približno 1 g/dl (0,62 mmol/l) na mesec in ne sme presegati 2 g/dl (1,25 mmol/l) na mesec, da se zmanjša tveganje zvišanja pri hipertenziji.
What Abseamed looks like and contents of the pack
Izgled zdravila Abseamed in vsebina pakiranja